Darolutamide in Spanish patients with nonmetastatic castration-resistant prostate cancer: ARAMIS subgroup analysis

  1. Carles, J.
  2. Medina-Lopez, R.A.
  3. Puente, J.
  4. Gómez-Ferrer, Á.
  5. Nebra, J.C.
  6. Sáez Medina, M.I.
  7. Ribal, M.J.
  8. Antolín, A.R.
  9. Álvarez-Ossorio, J.L.
  10. Suárez Novo, J.F.
  11. Agut, C.M.
  12. Srinivasan, S.
  13. Ortiz, J.
  14. Fizazi, K.
Aldizkaria:
Future Oncology

ISSN: 1744-8301,  1479-6694

Argitalpen urtea: 2023

Alea: 19

Zenbakia: 12

Orrialdeak: 819-828

Mota: Artikulua

DOI: 10.2217/FON-2022-1131 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus